Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04835844 · ClinicalTrials.gov registry record

RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation

A clinical trial of Paroxysmal Atrial Fibrillation, sponsored by The Cleveland Clinic.

Active
Registry status
49
Enrollment target
1
Study location

NCT04835844: Active study of Paroxysmal Atrial Fibrillation, sponsored by The Cleveland Clinic.

NCT04835844 is a study of Paroxysmal Atrial Fibrillation that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 49 participants, below the 857-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04835844, a study of Paroxysmal Atrial Fibrillation, is active but no longer recruiting, sponsored by The Cleveland Clinic.

ACTIVE NOT RECRUITING
Registry status
49 participants
Enrollment target
1
Study location

Study Summary

The MAP-AF study will compare RHYTHMIA vs CARTO in redo ablation of paroxysmal AF with assessment of both acute procedural profiles and clinical outcomes.

Primary Outcome

Incidence of accurate identification of gaps in prior ablation lines by the system

Conditions Studied

Paroxysmal Atrial Fibrillation

Interventions

  • DEVICE CARTO
  • DEVICE RHYTHMIA

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2020-07-24
Est. Completion 2026-07-01
The Cleveland Clinic

688 total trials

What the registry record for NCT04835844 still lists

NCT04835844 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 857-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which CARTO is the first listed.

NCT04835844 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04835844 about?

NCT04835844 is a clinical study titled "RHYTHMIA vs CARTO in Redo Ablation Procedures for Atrial Fibrillation". The MAP-AF study will compare RHYTHMIA vs CARTO in redo ablation of paroxysmal AF with assessment of both acute procedural profiles and clinical outcomes.

What is the current status of trial NCT04835844?

This trial is currently active not recruiting. The enrollment target is 49 participants. The study started on 2020-07-24. Estimated completion is 2026-07-01.

What conditions does trial NCT04835844 study?

This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation.

What interventions are being tested in trial NCT04835844?

The interventions under investigation include: CARTO (DEVICE), RHYTHMIA (DEVICE).

Who is sponsoring clinical trial NCT04835844?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04835844 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Paroxysmal Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04835844's enrollment target sits among peer trials

49 25th of 24 the lowest of 24 other Paroxysmal Atrial Fibrillation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Paroxysmal Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02704858 · 49 participants · Phase 1

    Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

  • NCT03516708 · 49 participants · Phase 1

    Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

  • NCT03692429 · 49 participants · Phase 1

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

  • NCT04329494 · 49 participants · Phase 1

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04835844, the US trial registry maintained by the National Library of Medicine. NCT04835844 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.